Texas Instruments Incorporated
Texas Instruments Incorporated (TXN) Financial Performance & Income Statement Overview
Analyze Texas Instruments Incorporated (TXN) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Texas Instruments Incorporated (TXN) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Texas Instruments Incorporated TXN financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $4.07B | $4.007B | $4.15B | $3.82B |
| Cost of Revenue | $1.76B | $1.69B | $1.68B | $1.61B |
| Gross Profit | $2.31B | $2.31B | $2.47B | $2.21B |
| Gross Profit Ratio | $0.57 | $0.58 | $0.60 | $0.58 |
| R&D Expenses | $517.00M | $491.00M | $492.00M | $498.00M |
| SG&A Expenses | $472.00M | $446.00M | $428.00M | $465.00M |
| Operating Expenses | $989.00M | $937.00M | $920.00M | $963.00M |
| Total Costs & Expenses | $2.75B | $2.63B | $2.60B | $2.57B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $128.00M | $130.00M | $131.00M | $131.00M |
| Depreciation & Amortization | $444.00M | $435.00M | $402.00M | $381.00M |
| EBITDA | $1.85B | $1.92B | $2.09B | $1.76B |
| EBITDA Ratio | $0.45 | $0.48 | $0.50 | $0.46 |
| Operating Income | $1.32B | $1.38B | $1.55B | $1.25B |
| Operating Income Ratio | $0.33 | $0.34 | $0.37 | $0.33 |
| Other Income/Expenses (Net) | -$48.00M | -$18.00M | $0.00 | -$1.00M |
| Income Before Tax | $1.28B | $1.36B | $1.55B | $1.25B |
| Income Before Tax Ratio | $0.31 | $0.34 | $0.37 | $0.33 |
| Income Tax Expense | $97.00M | $154.00M | $192.00M | $120.00M |
| Net Income | $1.18B | $1.21B | $1.36B | $1.13B |
| Net Income Ratio | $0.29 | $0.30 | $0.33 | $0.29 |
| EPS | $1.29 | $1.32 | $1.48 | $1.23 |
| Diluted EPS | $1.28 | $1.30 | $1.47 | $1.22 |
| Weighted Avg Shares Outstanding | $910.00M | $912.00M | $913.00M | $912.00M |
| Weighted Avg Shares Outstanding (Diluted) | $916.00M | $919.00M | $920.00M | $919.00M |
Over the last four quarters, Texas Instruments Incorporated achieved steady financial progress, growing revenue from $3.82B in Q2 2024 to $4.07B in Q1 2025. Gross profit stayed firm with margins at 57% in Q1 2025 versus 58% in Q2 2024. Operating income totaled $1.32B in Q1 2025, maintaining a 33% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $1.85B. Net income dropped to $1.18B, with EPS at $1.29. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan